Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSDevelopment of cell and gene therapies is among the most exciting innovations occurring in pharma research today. These treatments, which adapt a patient’s own genes and cells to treat inherited or acquired diseases, take personalized medicine to a new level.
As of 2019, the US Food and Drug Administration (FDA) has approved 19 of these treatments for conditions ranging from large B-cell lymphoma, to inherited blindness, to the appearance of wrinkles in adults. Industry analysts predict the market for cell and gene therapies will surpass $11.96 billion by 2025.
However it is still early days, and these treatments face a number of unique obstacles that make accurate commercial forecasting a huge challenge:
This kind of limited engagement and variability in outcomes makes forecasting a lot more complicated. Longevity and loyalty become irrelevant factors in the forecasting process, and every time a patient successfully uses your treatment (or your competitor’s) the potential patient pool shrinks, changing the forecast equation.
Lack of historical data, complicated payment structures, and custom production means forecasters need more sophisticated data analysis tools and strategies to deliver accurate predictions for cell and gene therapies.
Commercial forecasting tools for this treatment category need to be able to handle an order of magnitude more detail than is usually used for forecasting pharmaceutical or biotech products. They should be able to combine inputs from epidemiology analysis, the patient journey, market access and reimbursement, as well as manufacturing and supply chain, to establish accurate revenue and profit forecasts.
These days, increasingly sophisticated forecasting platforms, such as IQVIA’s Forecast Horizon, are leveraging the power of cloud computing and machine learning (ML) tools to enable this level of analysis, supporting the greater complexity while reducing manual input and adjustment. When forecasters have access to a platform with this level of detail, streamlined with automation, they can accelerate the forecasting process, gain accuracy, and adjust results on a constant basis as the patient population, payer environment and competition evolves.
To learn more about our approach to forecasting, click here or contact us at ForecastHorizon@iqvia.com
Insights specific to cell and gene therapy markets
Driving stem cell development from candidate identification through market authorization